Topics
May/June 2019 | Special Reports
Update on DRCR Retina Network Protocols
Recent results and ongoing trials shed light on the world of diabetic eye disease.
Chirag Jhaveri, MD
October 16, 2026
Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
October 15, 2026
Study Finds Rising Demand for Emergency Ophthalmology Consultations Across US Academic Centers
Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in DME
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
